A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers".
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
93pct
91d open
vs 82 other SJRES bills in the 116th — cohort avg 23d
This joint resolution rescinds the State Relief and Empowerment Waivers guidance issued on October 24, 2018, which relaxes the criteria for states to obtain waivers from certain health insurance plan coverage requirements.
Yes
43
No
52
Present
0
Not Voting
5
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (10)
Failed of passage in Senate by Yea-Nay Vote. 43 - 52. Record Vote Number: 337.
SenateFailed of passage/not agreed to in Senate: Failed of passage in Senate by Yea-Nay Vote. 43 - 52. Record Vote Number: 337.
SenateConsidered by Senate. (consideration: CR S6263-6271)
Measure laid before Senate by motion. (consideration: CR S6220-6225, S6228-6235)
Motion to proceed to consideration of measure agreed to in Senate by Voice Vote.
Motion to proceed to consideration of measure made in Senate. (CR S6220)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 278.
Senate Committee on Finance discharged by petition pursuant to 5 U.S.C. 802(c).
Senate Committee on Finance discharged by petition pursuant to 5 U.S.C. 802(c).
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| #337 | senate | On the Joint Resolution | Joint Resolution Defeated (43-52) | October 30, 2019 |
2020 · first_quarter · Health Issues
HR 6074- Coronavirus Preparedness and Response Supplemental Appropriations Act, protecting and training frontline workers during COVID-19 HR 748, S 3548- Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- protecting all state and local government frontline workers during COVID-19; increasing federal Medicaid match to states; increasing access to needed Personal Protective Equipment (PPE) HR 6201- Families First Coronavirus Response Act, (same provisions as HR 743/S 3548) plus protecting safety net hospitals from Medicaid cuts HR 6379- Take Responsibility for Workers and Families Act, (same provisions as HR 748/S 3548) Fourth COVID-19 Emergency Supplemental (same provisions as as HR 748/S 3548)HR 1629- 911 SAVES Act HR 4397- Direct Care Act HR 3- Lower Drug Costs Now Act HR 748- Middle Class Health Benefits Tax Act HR 3630- No Surprises Act SJ Res 52- Protect Affordable Care Act Federal income tax exclusion for employer-sponsored health care benefits Medicaid Federal Assistance Matching Percentage (FMAP)
Client expense: $670,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to the Department of Health and Human Services and Health-related line items Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 110:Medical Expense Savings Act; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Insurance
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for passage of H.R. 4393, the Advancing Access to Precision Medicine Act, provide for a State option under the State Medicaid plan to provide DNA sequencing clinical services for certain children. Advocated for funding for the FDA Orphan Products Grants Program. Advocated for passage of the Medical Nutrition Equity Act (H.R.2501). Advocated for Members to join the Rare Disease Caucus and the ALS Caucus. Advocated for passage of H.R. 3235, the Access to Genetic Counselor Services Act of 2019, to provide for expanded coverage of services provided by genetic counselors. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 2507 / S. 2158, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for increased funding for National Institutes of Health, Food and Drug Administration, Health Resources and Services Administration, and other health agencies that conduct research on neuromuscular disease and provide services to those with these conditions. Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019. Advocated for maintaining strong incentives for rare disease drug development included within the Orphan Drug Act (PL 97-414) Advocated for the continuance of the Rare Pediatric Disease Priority Review Voucher Program within the context of the Creating Hope Reauthorization Act (H.R.4439) Advocated for passage of Families First Coronavirus Response Act (HR 6201) and Coronavirus Preparedness and Response Supplemental Appropriations Act (HR 6704). Advocated for a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers" (H.J. Res. 74 / S.J. Res. 52).
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2020 · first_quarter · Insurance
Advocated for passage of the ALS Disability Insurance Act (HR 1407, S 578) which would eliminate the five month waiting period for individuals with ALS to obtain Social Security disability insurance. Advocated for passage of H.R. 4393, the Advancing Access to Precision Medicine Act, provide for a State option under the State Medicaid plan to provide DNA sequencing clinical services for certain children. Advocated for passage of H.R. 3235, the Access to Genetic Counselor Services Act of 2019, to provide for expanded coverage of services provided by genetic counselors. Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019. Advocated for passage of Families First Coronavirus Response Act (HR 6201). Advocated for a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers" (H.J. Res. 74 / S.J. Res. 52).
Client expense: $100,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
2020 · first_quarter · Health Issues
HR 6074- Coronavirus Preparedness and Response Supplemental Appropriations Act, protecting and training frontline workers during COVID-19 HR 748, S 3548- Coronavirus Aid, Relief, and Economic Security Act (CARES Act)- protecting all state and local government frontline workers during COVID-19; increasing federal Medicaid match to states; increasing access to needed Personal Protective Equipment (PPE) HR 6201- Families First Coronavirus Response Act, (same provisions as HR 743/S 3548) plus protecting safety net hospitals from Medicaid cuts HR 6379- Take Responsibility for Workers and Families Act, (same provisions as HR 748/S 3548) Fourth COVID-19 Emergency Supplemental (same provisions as as HR 748/S 3548)HR 1629- 911 SAVES Act HR 4397- Direct Care Act HR 3- Lower Drug Costs Now Act HR 748- Middle Class Health Benefits Tax Act HR 3630- No Surprises Act SJ Res 52- Protect Affordable Care Act Federal income tax exclusion for employer-sponsored health care benefits Medicaid Federal Assistance Matching Percentage (FMAP)
Client expense: $660,000 · Firm income: Not reported
2019 · fourth_quarter · Health Issues
Support H.R. 4701, the Health Equity & Access Under the Law (HEAL) for Immigrant Women and Families Act, which removes the five year waiting period for immigrants to become eligible for Medicaid and CHIP and ensures that individuals granted federally authorized presence, including DACA recipients, are eligible for federally funded health care programs; enables undocumented individuals to access health insurance coverage on the ACA health insurance exchanges and make them eligible to obtain premium tax credits and cost-sharing reductions; and restores Medicaid eligibility for COFA migrants Support final funding levels for the AIDS Budget and Appropriation Committees programs at the highest levels (generally those proposed by the House of Representatives), and to reject funding cuts proposed by the Senate Support the highest possible levels for domestic HIV programs, including the Ending the HIV Epidemic Initiative, and for programs that address the syndemics of hepatitis, STDs and tuberculosis., particularly for Housing for People With AIDS program Oppose the continued sales of mint and menthol e-cigarettes. Oppose the sale of flavored e-cigarettes Support health equity guidelines which lead to the reduction of health disparities; holds healthcare industry actors accountable; confronts the coverage gap; improves access to addiction care and safe medicines; promotes a diverse healthcare workforce; addresses he underrepresentation of diverse communities in clinical trials; supports breakthrough medical technologies and innovation; and revolutionizes value-based care Oppose proposal to carve out TRICARE providers from the Department of Labors Office of Federal Contract Compliance Programs jurisdiction Support H.R. 4995, the Maternal Health Quality Improvement Act, and H.R, 4996, the Helping Medicaid Offer Maternity Services Act, and support their inclusion in any end of year package. Together, these bills will improve the lives of American women and families by reversing our Nations maternal mortality trend Support the inclusion of S. 1895, the Lower Health Care Costs Act in any end-of-year spending bill. This legislation would end surprise medical bills and extend Medicare to 1-year post partum to help abate the Maternal Mortality problem Support H.R. 2339, the Reversing the Youth Tobacco Epidemic Act of 2019" which bans all characterizing flavors of tobacco products Support S. J. Res. 52, which overturns President Trumps proposal to further decrease the coverage of the Affordable Care Act (Obamacare). Under the new rule proposed by the Trump Administration and nullified by S. J. Res. 52, states would be permitted to allow, and even subsidize, health insurance plans which circumvent protections for Americans with preexisting conditions and dont cover essential benefits, like maternity care, preventive screening, and mental healthcare. Support H. R. 986,The Protecting Americans with Preexisting Conditions Act which nullifies the Trump Administrations guidance which allow states to forego certain requirements of the Patient Protection and Affordable Care Act (Obamacare). The requirements nullified by the Trump Administration guidance undermine the consumer protections established in the ACA by giving insurance companies permission to once again discriminate against people with pre-existing conditions.
2019 · fourth_quarter · Health Issues
Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) Prescription Drug Pricing Reduction Act (S. 2543) Put Patients First Act (H.R. 5036/S. 2836) A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers" (S.J. Res. 52) ENROLL Act (H.R. 1386/S. 1905) Helping Medicaid Offer Maternity Service (MOMS) Act (H.R. 4996) Maternal Health Quality Improvement Act (H.R. 4995)
Client expense: $133,750 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Insurance
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
2019 · fourth_quarter · Health Issues
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 19: Lower Costs, More Cures Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: More Efficient Tools to Realize Information for Consumers Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4698: Medical Records Access Fairness Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions Draft Legislation related to 21st Century Cures Act 2.0; all provisions Antibiotic Development Incentives discussions; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 110:Medical Expense Savings Act; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions Antibiotic Development Incentives discussions; all provisions
2019 · fourth_quarter · Medicare/Medicaid
Medicare issues impacting patients with rare diseases. Medicare Part D Program. Section 1115 Waivers. Section 1332: State Innovation Waivers. CMS-2019-0100-0562: Medicare and Medicaid Programs: CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements. S.J.Res.52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers".
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2019 · fourth_quarter · Health Issues
H.R.3, Lower Drug Costs Now Act, Entirety H.R. 1309/S.851, Workplace Violence Prevention for Health Care and Social Service Workers Act, Entirety H.R.748, Health Benefits Tax Repeal, Entirety Affordability of pharmaceuticals, generally S.684, Middle Class Health Benefits Tax Repeal, Entirety Treating gun violence as a public health epidemic related issues S.1357, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act, Entirety Nurse Overtime and Patient Safety Act, Entirety Prescription Drug Affordability and Access Act, Entirety Affordable Drug Manufacturing Act, Entirety Monitor the following: H.R.1109, the Mental Health Services for Students Act of 2019, Entirety H.R.3022, Patient Access Protection Act, Entirety S.1770, Resilience Investment, Support, and Expansion from Trauma Act or the RISE from Trauma Act, Entirety H.R. 2328, Reauthorizing and Extending Americas Community Health Act , Title IV, No Surprises Act S.1895, Lower Health Care Costs Act, Entirety Universal healthcare generally H.R. 2328, Reauthorizing and Extending Americas Community Health Act , Title IV, No Surprises Act S.1895, Lower Health Care Costs Act, Entirety S.2675, Study, Treat, Observe, and Prevent Neglected Diseases of Poverty Act, Entirety H.R.934, Health Benefits for Miners Act, Entirety S.J.Res.52, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers". H.R.1603, Ban Asbestos Now Act
Client expense: $450,000 · Firm income: Not reported
2019 · fourth_quarter · Health Issues
HR 3 "Lower Drug Costs Now Act of 2019," all provisions. HR 3708 "Primary Care Enhancement Act of 2019," all provisions. SJ Res 52 "A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to 'State Relief and Empowerment Waivers'," all provisions. Issues pertaining to "Surprise Medical Billing," price disclosure, penalties on insurers and providers for supplying false and misleading information about a facilitys network status, banning balance billing at non-network emergency departments, price setting, and arbitration proposals.
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law; Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; Cannabis research issues, including S. 2032 Cannabidiol and Marihuana Research Expansion Act and S. 2400Expanding Cannabis Research and Information Act ; H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 HR___, Medical Records Fairness Act (Rep. Bill Foster, D-IL); S. 2497, the Dependent Income Exclusion Act; SJ Res 52, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; Issues related to prescription drug costs - H.R. 3, the Lower Prescription Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act of 2019; Issues related to HHS regulation of prescription drug prices; H.R. 4439, Creating Hope Reauthorization Act; H.R. 1730 and S. 741, the Cancer Drug Parity Act; S. 2546 & H.R. 2279, the Safe Step Act of 2019 - amends the Employee Retirement Income Security Act (ERISA) to require group health plans to provide an exception process for any medication step therapy protocol, tools used by health plans to control spending on patients medications, to help ensure patients are able to safely and efficiently access treatment; S. 2911 - Seniors Prescription Drug Relief Act of 2019, would allow Medicare beneficiaries who reach an out of pocket cap to spread their payments over the course of the entire year; Issues related to cancer survivorship and transitions of care from oncology treatment back to primary care; S. 1608, the Promoting Physical Activity for Americans Act; and Issues related to the nomination of Dr. Stephen Hahn to be Commissioner of the Food and Drug Administration.
2019 · fourth_quarter · Insurance
HR 3630, HR 3502, S 1531, S 1895- Surprise Medical Bills S 1895- Lower Health Care Costs Act SJ Res 52- Protect individuals with pre-existing conditions from junk plans HR 4527- Expanding Health Care Options for Early Retirees Act
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
HR 1309, S 851- Workplace Violence Prevention for Health Care and Social Service Workers Rep. Byrne amendment in the nature of workplace violence as a substitute for HR 1309 HR 1865- Supporting Certified Community Behavioral Health Clinics HR 1865- Protecting public safety net hospitals from Medicaid cuts HR 3- Lowering Prescription Drug Prices HR 3630, HR 3502, S 1531, S 1895- Surprise Medical Bills; No Surprises Act S 1895- Lower Health Care Costs Act Home Care Volunteers HR 1603- Alan Reinstein Ban Asbestos Now Act of 2019 SJ Res 52- Protect individuals with pre-existing conditions from junk plans HR 4527- Expanding Health Care Options for Early Retirees Act Federal income tax exclusion for employer-sponsored health care benefits HR 748, S 684- 40% tax on employer-sponsored worker health benefits; including Middle Class Health Benefits Tax Repeal Act HR 1629- 911 EMS SAVES Act SJ Res 52- Protect Affordable Care Act
Client expense: $560,000 · Firm income: Not reported
2019 · third_quarter · Health Issues
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3 - Lower Drug Costs Now Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions The Medical Records Access Fairness Act draft; all provisions
2019 · third_quarter · Insurance
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
Client expense: $160,000 · Firm income: Not reported
2019 · third_quarter · Medicare/Medicaid
Medicare issues impacting patients with rare diseases. Medicare Part D Program. Section 1115 Waivers. Section 1332: State Innovation Waivers. CMS-2406-P2/RIN: 0938-AT41: Methods for Assuring Access to Covered Medicaid Services - Rescission. CMS-9936-NC2: Request for Information Regarding State Relief and Empowerment Waivers. S.J.Res.52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers".
Client expense: $60,000 · Firm income: Not reported
Government targets: Bureau of Citizenship & Immigration Services (BCIS), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
2019 · third_quarter · Insurance
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
Client expense: $160,000 · Firm income: Not reported
2019 · third_quarter · Health Issues
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3 - Lower Drug Costs Now Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions The Medical Records Access Fairness Act draft; all provisions
2019 · third_quarter · Health Issues
Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; Issues relating to curbing health care costs; H.R.647 & S. 2080, the Palliative Care and Hospice Education and Training Act; Anti-cancer medication cost-sharing parity respecting H.R. 1409; A national family caregiving strategy respecting S. 1719 and H.R. 1028; Access to medicines respecting FDA implementation of right to try law. Issues relating to FDA regulation of laboratory tests, Verifying Accurate Leading-edge IVCT Development Act of 2018 or the VALID Act of 2018; H.R. 4897 & S. 2358 Women and Lung Cancer Research and Preventive Services Act of 2018; H. Res. 282, supporting initiatives to encourage parents and guardians to take measures to prevent sunburns in minors they care for; H.R. 1966 & S 946, the Henrietta Lacks Enhancing Cancer Research Act of 2019, regarding decreasing disparities in access to cancer clinical trials; Additional issues related to reducing disparities in cancer clinical trials; Issues related to improving quality of life for cancer survivorship; H.R. 1948 & S. 518, the Lymphedema Treatment Act H.R. 2222 and S. 1107, the Women and Lung Cancer Research and Preventative Services Act; H.Res. 14 & S.Res. 223, Expressing support for the designation of DIPG Awareness Day H.R. 1730 and S. 741, the Cancer Drug Parity Act; and Cannabis research issues, including S. 2032. H.R. 2689 & S. 1438 the Breast Cancer Research Stamp Reauthorization Act H.R. 4078 & S. 2424 EARLY Act Reauthorization of 2019 HR___, Medical Records Fairness Act (Rep. Bill Foster, D-IL) S. 2497, the Dependent Income Exclusion Act SJ Res 52, A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers". Issues related to prescription drug costs - H.R. 3, the Lower Prescription Drug Costs Now Act and S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4439, Creating Hope Reauthorization Act
2019 · third_quarter · Insurance
HR 1730/S 741 Cancer Drug Parity Act HR 2428, ABCD Act S 1895, Lower Health Care Costs Act HR 986, HR 987, HR 1386, HR 1010, HR 1884 Diagnostic imaging for breast cancer patients and survivors Implementation of Affordable Care Act; Public Change; SJ Res 52 S 2543 Prescription Drug Price Relief Act HR 3 Lower Drug Costs Now Act of 2019
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Insurance
Implementation of the Affordable Care Act HR 1010 HR 1386, ENROLL ACT S 1895, Lower Healthcare Cost Act HR 986, Protecting Americans with Pre-Existing Conditions Act HR 987, Strengthening Health Care and Lowering Prescription Drugs Costs Act S.2543, Prescription Drug Price Relief Act HR. 3 Lower Drug Costs Now Act of 2019 SJ Res 52; Public Charge
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
Read twice and referred to the Committee on Finance.
Introduced in Senate
| Independent |
| VT |
| Brian Schatz | Democratic | HI |
| Catherine Cortez Masto | Democratic | NV |
| Charles E. Schumer | Democratic | NY |
| Chris Van Hollen | Democratic | MD |
| Christopher A. Coons | Democratic | DE |
| Christopher Murphy | Democratic | CT |
| Cory A. Booker | Democratic | NJ |
| Debbie Stabenow | Democratic | MI |
| Dianne Feinstein | Democratic | CA |
| Doug Jones | Democratic | AL |
| Edward J. Markey | Democratic | MA |
| Elizabeth Warren | Democratic | MA |
| Gary C. Peters | Democratic | MI |
| Jack Reed | Democratic | RI |
| Jacky Rosen | Democratic | NV |
| Jeanne Shaheen | Democratic | NH |
| Jeff Merkley | Democratic | OR |
| Joe Manchin, III | Independent | WV |
| Jon Tester | Democratic | MT |
| Kamala D. Harris | Democratic | CA |
| Kirsten E. Gillibrand | Democratic | NY |
| Kyrsten Sinema | Independent | AZ |
| Margaret Wood Hassan | Democratic | NH |
| Maria Cantwell | Democratic | WA |
| Martin Heinrich | Democratic | NM |
| Mazie K. Hirono | Democratic | HI |
| Michael F. Bennet | Democratic | CO |
| Patrick J. Leahy | Democratic | VT |
| Patty Murray | Democratic | WA |
| Richard Blumenthal | Democratic | CT |
| Richard J. Durbin | Democratic | IL |
| Robert Menendez | Democratic | NJ |
| Robert P. Casey, Jr. | Democratic | PA |
| Ron Wyden | Democratic | OR |
| Sheldon Whitehouse | Democratic | RI |
| Sherrod Brown | Democratic | OH |
| Tammy Baldwin | Democratic | WI |
| Tammy Duckworth | Democratic | IL |
| Thomas R. Carper | Democratic | DE |
| Tim Kaine | Democratic | VA |
| Tina Smith | Democratic | MN |
| Tom Udall | Democratic | NM |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $72,500 · Firm income: Not reported
Government targets: AMTRAK - Natl Railroad Passenger Corporation, Agriculture, Dept of (USDA), Consumer Financial Protection Bureau (CFPB), Education, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Housing Finance Agency (FHFA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), U.S. Postal Service (USPS), White House Office
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
Client expense: $1,650,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $1,230,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office